The proposed EU transparency directive - will it support the evolving pricing & reimbursement landscape for pharma?
This article was originally published in SRA
Maarten Meulenbelt discusses the European Commission's long-awaited draft of a new transparency directive and considers its potential impact on industry and regulators.
You may also be interested in...
Results of a pivotal trial show BrainCool’s Cooral system is significantly more effective than the standard of care therapy in preventing oral mucositis in lymphoma patients.
Centaur-CytoTools introduces novel topical treatment for diabetic foot ulcers in India, for which they see limited direct competition and hope to change the way the difficult-to-treat diabetes complication is managed. Phase III studies are ongoing in Europe.
The head of the US Food and Drug Administration praised the life-saving work of device center staff in response to the coronavirus pandemic.